-
公开(公告)号:DK370875A
公开(公告)日:1976-02-17
申请号:DK370875
申请日:1975-08-15
Applicant: HOECHST AG
Inventor: OBERMEIER R , GEIGER R
IPC: C07K14/575 , C07K1/113 , C07K14/62 , C07C
-
公开(公告)号:SE7500423L
公开(公告)日:1975-07-17
申请号:SE7500423
申请日:1975-01-15
Applicant: HOECHST AG
Inventor: HEROLD H , OBERMEIER R
IPC: C07C41/00 , C10M105/18 , C07C43/11 , C07C43/13 , C07C67/00 , C08G65/26 , C08G65/28 , C09K23/42 , C10M169/00 , C10N30/08 , C10N40/08 , C07C43/04
Abstract: 1480432 Polyethers HOECHST AG 13 Jan 1975 [16 Jan 1974] 1339/75 Heading C2C [Also in Division C5] Novel polyethers having the formula wherein R is (C 1 -C 4 )alkyl, x and z are 1, 2 or 3, are prepared by the reaction of an ether of the formula ROÀ(CH 2 CHO) x H or a mixture thereof, with ethylene oxide and propylene oxide at an elevated temperature and pressure in the presence of an alkaline catalyst, by either (a) reacting an excess of the ether in a first reaction step with propylene oxide and, after removal of the excess starting ether, reacting the product obtained in a second reaction step with ethylene oxide, or (b) reacting ethylene oxide, propylene oxide and an excess of the ether, relative to the oxide mixture, and distilling the mixture under reduced pressure to obtain a sump product consisting of the final product. The novel compounds can be used as brake fluids.
-
公开(公告)号:SE442195B
公开(公告)日:1985-12-09
申请号:SE7710021
申请日:1977-09-07
Applicant: HOECHST AG
Inventor: SCHEFFEL G , OBERMEIER R
IPC: B01J27/00 , B01J31/00 , C07B61/00 , C07C41/00 , C07C41/02 , C07C43/10 , C07C43/11 , C07C43/12 , C07C43/13 , C07C43/164 , C07C43/174 , C07C67/00 , C07C43/02
Abstract: of the disclosure: Oxalkylene groups of oxacycloalkanes are inserted into chain-type ethers by reacting the latter with the oxacycloalkanes in the presence of Lewis acids. The ethers or ether mixtures obtained can be used for many purposes owing to their hydrophilic-hydrophobic character, for example as absorption and extraction agents, as solvents and as additives to hydraulic fluids.
-
-
公开(公告)号:SE7710021L
公开(公告)日:1978-03-10
申请号:SE7710021
申请日:1977-09-07
Applicant: HOECHST AG
Inventor: SCHEFFEL G , OBERMEIER R
IPC: B01J27/00 , B01J31/00 , C07B61/00 , C07C41/00 , C07C41/02 , C07C43/10 , C07C43/11 , C07C43/12 , C07C43/13 , C07C43/164 , C07C43/174 , C07C67/00 , C07C43/02
Abstract: of the disclosure: Oxalkylene groups of oxacycloalkanes are inserted into chain-type ethers by reacting the latter with the oxacycloalkanes in the presence of Lewis acids. The ethers or ether mixtures obtained can be used for many purposes owing to their hydrophilic-hydrophobic character, for example as absorption and extraction agents, as solvents and as additives to hydraulic fluids.
-
公开(公告)号:DK154077A
公开(公告)日:1977-10-09
申请号:DK154077
申请日:1977-04-06
Applicant: HOECHST AG
Inventor: KOENIG W , GEIGER R , OBERMEIER R , TEETZ V
IPC: A61K38/22 , C07K14/575 , C07K1/14 , C07K14/645 , C07C
Abstract: A process for the purification of secretin by chromatography on an alkylated dextran gel is disclosed, as is a method of its manufacture appropriate for preparing larger amounts of secretin.
-
公开(公告)号:NZ215585A
公开(公告)日:1988-03-30
申请号:NZ21558586
申请日:1986-03-25
Applicant: HOECHST AG
Inventor: OBERMEIER R
Abstract: The invention relates to a process for the isolation and purification of alpha -interferons by (a) dissolution of the interferon-containing crude product in guandine. HCl solution and precipitation by dilution with water and/or (b) by chromatography on an HIC column under renaturing conditions.
-
公开(公告)号:NZ209620A
公开(公告)日:1988-03-30
申请号:NZ20962084
申请日:1984-09-21
Applicant: HOECHST AG
Inventor: GRAU U , GEIGER R , OBERMEIER R
Abstract: 1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE A medicament having a delayed action for the treatment of diabetes mellitus, comprising at least one insulin derivative of the formula I see diagramm : EP0137361,P16,F1 in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH2 and des-B30 human insulin Phe**B30 -NH2 and a pharmaceutically acceptable carrier. 1. Claims for the Contracting State : AT A process for the preparation of a medicament having a delayed action for the treatment of diabetes mellitus, which comprises bringing into a suitable dosage form at least one insulin derivative of the formula I see diagramm : EP0137361,P17,F1 in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH, and des-B30 human insulin Phe**B30 -NH2 Phe**B30 -NH2 and a pharmaceutically acceptable carrier.
-
公开(公告)号:DK16682A
公开(公告)日:1982-07-18
申请号:DK16682
申请日:1982-01-15
Applicant: HOECHST AG
Inventor: OBERMEIER R , LUDWIG J , SEIPKE G
Abstract: What is disclosed is a method for making human insulin or modified human insulin from pig insulin or modified pig insulin by reacting the pig insulin starting material at a pH below its isoelectric point with an excess of a threonine ester in the presence of trypsin or a trypsin-like enzyme.
-
公开(公告)号:ZA755B
公开(公告)日:1976-01-28
申请号:ZA755
申请日:1975-01-02
Applicant: HOECHST AG
Inventor: HEROLD H , OBERMEIER R
IPC: C07C41/00 , C10M105/18 , C07C43/11 , C07C43/13 , C07C67/00 , C08G65/26 , C08G65/28 , C09K23/42 , C10M169/00 , C10N30/08 , C10N40/08 , C08G
Abstract: 1480432 Polyethers HOECHST AG 13 Jan 1975 [16 Jan 1974] 1339/75 Heading C2C [Also in Division C5] Novel polyethers having the formula wherein R is (C 1 -C 4 )alkyl, x and z are 1, 2 or 3, are prepared by the reaction of an ether of the formula ROÀ(CH 2 CHO) x H or a mixture thereof, with ethylene oxide and propylene oxide at an elevated temperature and pressure in the presence of an alkaline catalyst, by either (a) reacting an excess of the ether in a first reaction step with propylene oxide and, after removal of the excess starting ether, reacting the product obtained in a second reaction step with ethylene oxide, or (b) reacting ethylene oxide, propylene oxide and an excess of the ether, relative to the oxide mixture, and distilling the mixture under reduced pressure to obtain a sump product consisting of the final product. The novel compounds can be used as brake fluids.
-
-
-
-
-
-
-
-
-